Ausdal Financial Partners, Inc. Oncolytics Biotech Inc Transaction History
Ausdal Financial Partners, Inc.
- $897 Million
- Q3 2024
A detailed history of Ausdal Financial Partners, Inc. transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Ausdal Financial Partners, Inc. holds 14,000 shares of ONCY stock, worth $11,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,000
Previous 21,000
33.33%
Holding current value
$11,900
Previous $20,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ONCY
# of Institutions
44Shares Held
1.18MCall Options Held
0Put Options Held
0-
Seeds Investor LLC New York, NY190KShares$161,4490.06% of portfolio
-
International Assets Investment Management, LLC Orlando, FL174KShares$148,1810.55% of portfolio
-
Goldman Sachs Group Inc New York, NY85KShares$72,2480.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il79.2KShares$67,3610.0% of portfolio
-
Royal Bank Of Canada Toronto, A674.5KShares$63,3640.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $49.2M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...